Showing results (51-60 of 85) with videos related to
Sort By:
Pageof 9
European Journal of Clinical Pharmacology|January 1, 1986
Pharmacokinetics and metabolism of quinidine in extensive and poor metabolisers of sparteineG Mikus, H R Ha, S Vozeh, et al.Anesthesiology|January 1, 1987
Population pharmacokinetics of alfentanil: the average dose-plasma concentration relationship and interindividual variability in patientsP O Maitre, S Vozeh, J Heykants, et al.The American Review of Respiratory Disease|August 1, 1978
Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumoniaJ R Powell, S Vozeh, P Hopewell, et al.American Heart Journal|April 1, 1987
Computer-assisted individualized lidocaine dosage: clinical evaluation and comparison with physician performanceS Vozeh, T Uematsu, R Ritz, et al.The American Journal of Cardiology|March 1, 1987
Pharmacodynamics of 3-hydroxyquinidine alone and in combination with quinidine in healthy personsS Vozeh, M Bindschedler, H R Ha, et al.Journal of Chemical Theory and Computation|December 1, 2015
Molecular Dynamics and Room Temperature Vibrational Properties of Deprotonated Phosphorylated SerineA Cimas, P Maitre, G Ohanessian, et al.The American Review of Respiratory Disease|February 1, 1982
Theophylline serum concentration and therapeutic effect in severe acute bronchial obstruction: the optimal use of intravenously administered aminophyllineS Vozeh, G Kewitz, A Perruchoud, et al.Clinical Pharmacokinetics|February 1, 1996
The use of population pharmacokinetics in drug developmentS Vozeh, J L Steimer, M Rowland, et al.JAMA|October 20, 1978
Changes in theophylline clearance during acute illnessS Vozeh, J R Powell, S Riegelman, et al.European Journal of Clinical Pharmacology|January 1, 1994
Population approaches in drug development. Report on an expert meeting to discuss population pharmacokinetic/pharmacodynamic softwareL Aarons, L P Balant, F Mentré, et al.Pageof 9